MAPK3 and lung adenocarcinoma: This chemokine not only triggers MUC5AC expression through the ERK1/2-SP1 signaling cascade but also binds to its receptors on lung adenocarcinoma cells, activating the ERK1/2 pathway and enhancing SP1 binding to the MUC5AC gene promoter.